Caris Life Sciences is experiencing rapid growth, leveraging AI and molecular science for personalized medicine. Click here ...

Caris Life Sciences (CAI) priced 23.53M shares at $21.00. The deal priced above the $19.00-$20.00 range. BofA, JPMorgan and Goldman Sachs acted as joint book running managers for the offering. Caris ...

Despite raising the price of its IPO twice, Caris Life Sciences Inc. left money on the table with a 33% increase in price as ...

The latest health news includes Brazil facing international chicken trade restrictions due to bird flu, new weight-loss ...

Caris Life Sciences, a company that uses artificial-intelligence ... The company priced its IPO at $21 a share, above its offering range, and raised nearly $500 million from the stock sale.